Share Prices & Company Research

Stockbroking

AstraZeneca

Current Price 5463.65p Bid 5478.00p Ask 5479.00p Change 0.92%
Last Updated: 26/05/2018 11:08. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

AstraZeneca plc is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Financial Highlights Year Ended 31/12/2017

Turnover
£22,465.00m
Operating Profit
£3,677.00m
Dividend Yield
3.71
Dividend Per Share
202.50
Dividend Cover
1.17
P/E Ratio
23.01

Key Personnel

Pascal Claude Roland Soriot
Chief Executive Officer
Marc Pierre Jean Dunoyer
Chief Financial Officer
Leif Valdemar Johansson
Non-Executive Chairman
Prof Geneviève Bernadette Berger
Non-Executive Director
Graham Andrew Chipchase
Non-Executive Director
Rudolph Harold Peter Markham
Non-Executive Director
Baroness Shriti Vadera
Non-Executive Director
Marcus Wallenberg
Non-Executive Director
Sherilyn Dawn McCoy
Non-Executive Director
Deborah DiSanzo
Non-Executive Director
Philip Arthur John Broadley
Non-Executive Director
Prof Sabera Nazneen Rahman
Non-Executive Director

Stock Details

EPIC
AZN
ISIN
GB0009895292
Shares in Issue
1,266,613,555
Market cap
£69,081.10m

Analyst Views (15)

Strong Buy
 
60.00%
Buy
 
20.00%
Hold
 
20.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
5478.00p
Bid Price
5478.00p
Ask Price
5479.00p
Volume
2547466
Change Today
50.00p
% Change Today
0.92%
Open
5469.00p
Previous Close
5478.00p
Intraday High
5490.00p
Intraday Low
5435.00p
52 Week High
5520.00p
52 Week Low
4260.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

AstraZeneca Intra-day Chart

AstraZeneca News

News in this section is provided by MoneyAM

FTSE closes up after seesaw afternoon 25 May 2018 | 16:38 FTSE stalls as UK growth fears confirmed 25 May 2018 | 11:59 Broker Forecast - Shore Capital issues a broker note on AstraZeneca PLC 25 May 2018 | 11:10 Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC 25 May 2018 | 10:20 UK stocks open stronger as North Korea tensions cool 25 May 2018 | 09:02 AstraZeneca lung cancer treatment shows positive results in clinical trial 25 May 2018 | 07:19 Strong US open boosts FTSE 21 May 2018 | 17:02 FTSE rises on de-escalation of US-China trade tensions 21 May 2018 | 11:48 Broker Forecast - Bernstein issues a broker note on AstraZeneca PLC 21 May 2018 | 11:30 UK stocks open 0.6% higher as trade war fears abate 21 May 2018 | 09:04 AstraZeneca submits application for diabetes treatment in Japan 21 May 2018 | 07:28 AstraZeneca hyperkalaemia drug gets FDA approval 21 May 2018 | 07:13 Weak mining stocks drag the FTSE lower 18 May 2018 | 16:39 FTSE retreats from record high 18 May 2018 | 11:54 Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC 18 May 2018 | 11:10 UK stocks open 0.2% lower as AstraZeneca disappoints 18 May 2018 | 09:03 AstraZeneca first-quarter profit falls 36% on lower revenue 18 May 2018 | 07:53 FTSE rallies into the close, new record in sight 11 May 2018 | 16:37 Weak utility stocks stall FTSE 11 May 2018 | 11:45 FTSE 100 struggles for direction 11 May 2018 | 09:03 Stocks tread water ahead of Trump decision on Iran deal 08 May 2018 | 16:38 Oil price reverse weighs on FTSE 08 May 2018 | 11:55 Miners lift FTSE 08 May 2018 | 09:06 AstraZeneca sells rights to Seroquel to Luye Pharma for $538m 08 May 2018 | 07:27 AstraZeneca lung cancer treatment gets positive opinion from European regulators 27 Apr 2018 | 13:04 Broker Forecast - Shore Capital issues a broker note on AstraZeneca PLC 24 Apr 2018 | 09:00 Broker Forecast - Shore Capital issues a broker note on AstraZeneca PLC 19 Apr 2018 | 11:30 FTSE edges higher on steady global equities 19 Apr 2018 | 08:57 AstraZeneca lung cancer drug Tagrisso gets FDA approval 19 Apr 2018 | 07:40 FDA accepts Astrazeneca's Biologics License Application for moxetumomab pasudotox 03 Apr 2018 | 07:43

Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Tangible Assets
7,615.0
6,848.0
Intangible Assets & Goodwill
38,013.0
39,244.0
Investments & Other Non-Current Assets
4,576.0
3,172.0
Total Non-Current Assets
50,204.0
49,264.0
Inventory
3,035.0
2,334.0
Trade & Receivables
5,009.0
4,573.0
Cash & Receivables
3,324.0
5,018.0
Other Current Assets & Assets Held for Resale
1,782.0
1,337.0
Total Assets
63,354.0
62,526.0

Liabilities (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Short Term Liabilities
16,383.0
15,256.0
Long Term Liabilities
30,329.0
30,601.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
46,712.0
45,857.0

Net Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Net Assets
16,642.0
16,669.0

Equity (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Share Capital
317.0
316.0
Minority Interests
1,682.0
1,815.0
Retained Earnings
8,221.0
8,140.0
Share Premium Account
4,393.0
4,351.0
Other Equity
2,029.0
2,047.0
Total Equity
16,642.0
16,669.0

Cashflow (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Cashflow from Operating Activities
3,578.0
4,145.0
Cashflow Before Financing
1,250.0
176.0
Increase / Decrease in Cash
-1,686.0
-1,148.0

Income (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Turnover
22,465.0
23,002.0
Cost of Sales
4,318.0
4,126.0
Gross Profit
18,147.0
18,876.0
Operating Profit
3,677.0
4,902.0
Pre-Tax Profit
2,227.0
3,552.0
Profit / Loss for the Year
2,868.0
3,406.0

Dividend History

Data has been provided by MoneyAM

Period
Ex-Dividend Date
Payment Date
H2 Dividend
15 Feb 2018
19 Mar 2018
H1 Dividend
10 Aug 2017
11 Sep 2017
H2 Dividend
16 Feb 2017
20 Mar 2017
H1 Dividend
11 Aug 2016
12 Sep 2016
H2 Dividend
18 Feb 2016
21 Mar 2016
H1 Dividend
13 Aug 2015
14 Sep 2015
H2 Dividend
19 Feb 2015
23 Mar 2015
H1 Dividend
13 Aug 2014
15 Sep 2014
H2 Dividend
19 Feb 2014
24 Mar 2014
H1 Dividend
14 Aug 2013
16 Sep 2013
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.